Categories: Press-Releases

Beijing Handian Pharamceutical Held an Expert Seminar About TCM Global Application In Beijing


BEIJING–()–Last month, Beijing Handian Pharamceutical held an expert seminar about “Application of traditional Chinese medicine under the new situation of global health”. At this meeting, the company invited a number of experts from the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences to discuss the popularization of Chinese medicine and help the international society get through this difficult time.

The seminar first discussed the main reason causes the traditional Chinese medicine hardly used in other countries, which including the complex and rich effects of Chinese herbal medicines, the combination of different herbal medicines is profound and varied, and the methods of cooking are diverse and strict. Then the seminar focused on how to use modern scientific research technology to study Chinese medicine, and standardize and normalize Chinese medicine to make this ancient wisdom benefit the world. And that is what Beijing Handian Pharmaceutical are trying to achieve now.

Beijing Handian Pharmaceutical Co., Ltd. is a national high-tech enterprise integrating production, education and research. The company takes“Sincerity of Great Physician”as its core concept. While adhering to the theory of traditional Chinese medicine and inheriting classics of traditional Chinese medicine, it exerts its own scientific research strength and combines modern science and technology to develop a variety of classic Chinese patent medicines, such as Handian HD1 for frailty diseases, Handian HD2 for typhoid, exogenous diseases and influenza, Handian HD3 for digestive system diseases, etc. These medicines come from the classics of traditional Chinese medicine. The company combines the ancient wisdom of traditional Chinese medicine with modern medical technology to make it reborn in a modern society. It is easier to be accepted by more countries and cultures and contribute to social health.

In the future, the company hopes to rely on its own strong scientific research strength to develop more Chinese patent medicine products that are more suitable for European and American physiques and more easily accepted by European and American people. The Handian medical and health platform will also be launched soon, which will share the medical resources of Handian TCM hospitals online to benefit people all around the world.



Source link

The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

Business Wire

Recent Posts

Share repurchase programme

[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…

1 week ago

Gyroscope Market Size, Share And Growth Analysis For 2024-2033

[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…

1 week ago

Casting Off the Caste System and its Stigma: Empowering the Forgotten Indigenous People of India with Human Rights

[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…

1 week ago

Alipay+ Enables Digital Payment of 14 Overseas E-wallets from 9 Countries and Regions in Hong Kong to Support City’s Global Travel Drive

In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…

1 week ago

Celebrate "Bleach: Brave Souls" Reaching Over 90 Million Downloads Worldwide with "The Future Society Zenith Summons: Cyber" Featuring New Versions of Ulquiorra, Orihime, and Nnoitora

[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…

1 week ago

TransAlta Declares Dividends

[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…

2 weeks ago